ArticleCureus2025
Beyond Ischemia: A Curious Case of Electrocardiographic Abnormalities in COVID-19 Without Myocardial Injury.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
T-wave inversion (TWI) on electrocardiography (ECG) is a nonspecific finding that may reflect a wide range of cardiac and non-cardiac conditions. Since the emergence of COVID-19, there has been growing recognition of its diverse cardiovascular manifestations, including ECG abnormalities in the absence of traditional causes such as coronary artery disease. We present a case of significant TWI and QTc prolongation in a patient with COVID-19, underscoring the potential impact of the virus on cardiac electrophysiology and autonomic regulation. A 68-year-old woman with a history of paroxysmal atrial fibrillation presented with dizziness and hypotension. ECG revealed marked TWI and QTc prolongation, despite normal troponin levels. She tested positive for COVID-19, though her course did not require respiratory support. Further evaluation with echocardiography and coronary angiography excluded ischemic or structural heart disease, and alternative non-cardiac metabolic causes of TWI were also excluded. The findings were, therefore, attributed to autonomic dysfunction in the setting of COVID-19 infection. Her symptoms and ECG changes resolved over six months, consistent with a transient process. This case highlights the variable cardiac manifestations associated with COVID-19 and emphasizes the importance of recognizing TWI as a possible indicator of viral-induced cardiac involvement, even in the absence of conventional cardiovascular disease. It also reinforces the need for careful interpretation of ECG abnormalities in this population, given their potential prognostic significance. The transient course observed here suggests a reversible mechanism, possibly related to autonomic imbalance or direct viral effects on myocardial conduction. Further investigation is warranted to better delineate these mechanisms and inform targeted management strategies for patients with COVID-19-related cardiac involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.